<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2F6B0E70-1EDE-47A7-B3C4-27EF207152C7"><gtr:id>2F6B0E70-1EDE-47A7-B3C4-27EF207152C7</gtr:id><gtr:name>Julich Research Centre</gtr:name><gtr:address><gtr:line1>Forschungzentrum Julich GmbH</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFBF2A7E-9CB1-4B05-A7C8-88903332FF09"><gtr:id>AFBF2A7E-9CB1-4B05-A7C8-88903332FF09</gtr:id><gtr:name>Cochin Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B6C2A2B-0BBF-4E20-B1B7-5226C468099C"><gtr:id>4B6C2A2B-0BBF-4E20-B1B7-5226C468099C</gtr:id><gtr:name>Rockefeller University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/109020B0-5900-49F7-980F-01DA20C7C0EE"><gtr:id>109020B0-5900-49F7-980F-01DA20C7C0EE</gtr:id><gtr:name>MRC Cell Biology Unit</gtr:name><gtr:address><gtr:line1>University College London</gtr:line1><gtr:line2>Gower Street</gtr:line2><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/109020B0-5900-49F7-980F-01DA20C7C0EE"><gtr:id>109020B0-5900-49F7-980F-01DA20C7C0EE</gtr:id><gtr:name>MRC Cell Biology Unit</gtr:name><gtr:address><gtr:line1>University College London</gtr:line1><gtr:line2>Gower Street</gtr:line2><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2F6B0E70-1EDE-47A7-B3C4-27EF207152C7"><gtr:id>2F6B0E70-1EDE-47A7-B3C4-27EF207152C7</gtr:id><gtr:name>Julich Research Centre</gtr:name><gtr:address><gtr:line1>Forschungzentrum Julich GmbH</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFBF2A7E-9CB1-4B05-A7C8-88903332FF09"><gtr:id>AFBF2A7E-9CB1-4B05-A7C8-88903332FF09</gtr:id><gtr:name>Cochin Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B6C2A2B-0BBF-4E20-B1B7-5226C468099C"><gtr:id>4B6C2A2B-0BBF-4E20-B1B7-5226C468099C</gtr:id><gtr:name>Rockefeller University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/81F258C5-810B-429A-A3F7-1BC798808331"><gtr:id>81F258C5-810B-429A-A3F7-1BC798808331</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Marsh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U122665002"><gtr:id>EC4A1936-EFC5-4A98-9495-B8F90EF7A313</gtr:id><gtr:title>Membrane traffic pathways in viral replication and pathogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U122665002</gtr:grantReference><gtr:abstractText>We study the human immunodeficiency virus (HIV) that is linked to AIDS and is believed to have infected 60 million people worldwide. During infection these viruses must interact with receptor proteins expressed on the surfaces of target cells. Using the natural binding proteins of these receptors, it is possible to abrogate HIV infection. We are trying to understand the cellular and molecular mechanisms that underlie this regulation with the aim of developing novel strategies to down regulate the receptors. Such strategies may have efficacy against HIV. Importantly, the receptors exploited by HIV are representative of a large class of similar proteins, so-called G protein coupled receptors (GPCRs), that control a range of biological functions including the immune system. So what we learn about HIV receptors may have relevance to other important biological events.||In addition to understanding virus entry, we also investigate the molecular and cellular mechanisms involved in the formation of new virus particles within infected cells. This requires that the key structural proteins that make up virus particles are bought together at the same time and place within an infected cell so that virus particles can form. We have identified molecular signals in the envelope glycoprotein that are required for the correct trafficking within infected cells. When one of these signals is mutated in a simian model system, the virus is attenuated and is no longer pathogenic. Moreover, animals treated with this virus are protected against challenge with normal pathogenic viruses. Together these studies are providing novel insights to the mechanisms of pathogenesis and may give hints to the key components of immune control.</gtr:abstractText><gtr:technicalSummary>We focus on understanding; (i) the mechanisms controlling cell surface expression of cellular receptors for HIV and (ii) the mechanisms involved in the assembly of HIV virions.||Project 1: Human immunodeficiency virus (HIV), the etiological agent of AIDS, infects cells by membrane fusion following interaction with receptors expressed on surfaces of target cells. Two different cell surface glycoproteins form the functional virus receptor - CD4 and a member of the chemokine receptor family of G protein-coupled receptors (GPCRs). Two chemokine receptors have been linked to HIV infection, CC chemokine receptor 5 (CCR5) and CXC chemokine receptor 4 (CXCR4). The agonists for these receptors can protect cells from infection by inducing their endocytosis. We are studying the mechanism of chemokine receptor internalisation and the fate of the internalised molecules. Although focused on chemokine receptors, these studies have relevance for understanding the regulation of a variety of other GPCRs.||Project 2: To make new HIV particles, the essential proteins of the virus must be bought together at the same time and place within infected cells. Structurally, HIV is a relatively simple virus and requires just three virally encoded proteins to make new infectious particles, namely Envelope (Env), Gag and Gag-Pol. We are trying to understand how these proteins are sorted and traffic within cells in order to produce viral particles. We have found that in primary human macrophages, infected with HIV in tissue culture, the assembly events occur on the membranes of a novel intracellular multivesicular compartment. This internal assembly may convey distinct biochemical and functional properties on virus particles and enable release of infectious virus to be regulated and coordinated with the presence of appropriate target cells, such as CD4 positive T cells. Experiments are in progress to determine how the viral components target this compartment and the normal biological functions of this compartment. Significantly, we have found that the Env protein contains conserved signals that control its intracellular trafficking, in part these signals mediate endocytosis and keep the level of Env expressed at the cell surface low. Significantly, in a monkey model, mutation of these signals in the closely related simian immunodeficiency viruses (SIV) leads to attenuation of the pathological potential of the virus. Moreover, animals treated with such viruses show protection when challenged with pathogenic viruses. We hypothesis that correct signals in the structural components of the virus are required to allow efficient assembly of infectious virions and that in animals challenged with viruses lacking the correct signals in the viral structural proteins, the immune system is able to control infection and protect against challenge with non-attenuated viruses.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>7116161</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leuven</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Mode of action of HIV replication inhibitor: CADA</gtr:description><gtr:id>A9278C98-9386-411D-8A4C-3627D2EB041F</gtr:id><gtr:impact>A paper is in press in PLOS Biology, other abstracts have been published in meeting reports.</gtr:impact><gtr:outcomeId>54648d8c073cd4.01552281-1</gtr:outcomeId><gtr:partnerContribution>The partners were able to show that CADA can reversibly bind the signal peptide of the nascent human CD4 within the ER translocon and thereby inhibit synthesis of new protein.</gtr:partnerContribution><gtr:piContribution>My lab contributed to understanding that CADA can specifically down regulate human CD4 by inhibiting the synthesis of the molecule.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Infectious Synapse and Transmission of Disease</gtr:description><gtr:id>72331FE2-2ECE-4F73-A77B-2BFDE95791DA</gtr:id><gtr:impact>PMID:19143628</gtr:impact><gtr:outcomeId>B3D7A51F36D-1</gtr:outcomeId><gtr:partnerContribution>Program provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagents</gtr:partnerContribution><gtr:piContribution>We provide cell biological expertise and experimental models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Regulation of GPCR signalling through endocytic trafficking</gtr:description><gtr:id>DC5839FE-B94B-42E2-897C-8ACDC5CB78DB</gtr:id><gtr:impact>Two papers have been published to date.</gtr:impact><gtr:outcomeId>54648eb8258040.66809385-1</gtr:outcomeId><gtr:partnerContribution>The partners have provided conceptual input to the work, as well as live cell imaging, data analysis and contributions to the writing of research papers.</gtr:partnerContribution><gtr:piContribution>My group has provided conceptual input to the work, as well as electron microscopy, data analysis and contributions to the writing of research papers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rockefeller University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Infectious Synapse and Transmission of Disease</gtr:description><gtr:id>BE5C65AD-AF07-4CF2-B864-8431EBE68FC9</gtr:id><gtr:impact>PMID:19143628</gtr:impact><gtr:outcomeId>B3D7A51F36D-2</gtr:outcomeId><gtr:partnerContribution>Program provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagents</gtr:partnerContribution><gtr:piContribution>We provide cell biological expertise and experimental models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Perelman School of Medicine</gtr:department><gtr:description>Env trafficking signals in SIV pathogenesis</gtr:description><gtr:id>3816955E-F3FE-44BA-880B-77EE3728B055</gtr:id><gtr:impact>Nine publications

Multi-diciplinary: Virology, cell biology, in vivo animal models</gtr:impact><gtr:outcomeId>Ds2u1XGPWyK-1</gtr:outcomeId><gtr:partnerContribution>Virological and in vivo studies that complement the cell biology.</gtr:partnerContribution><gtr:piContribution>Cell biological analysis of the role of trafficking signals in the cytoplasmic domain of the simian immunodeficiency virus envelope protein - a model for understanding HIV pathogenesis and anti-viral immune responses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cochin Institute (Institut Cochin)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>HIV-ACE</gtr:description><gtr:id>87E46D7A-C6B6-46C3-989C-769E431FE263</gtr:id><gtr:impact>PMID:19864625</gtr:impact><gtr:outcomeId>A79372A9C73-1</gtr:outcomeId><gtr:partnerContribution>Partners provide access to experiment data and novel reagents.</gtr:partnerContribution><gtr:piContribution>EU funded project to identify inhibitor of HIV assembly. We contribute cell biological expertise and SIV model.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Julich Research Centre</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Infectious Synapse and Transmission of Disease</gtr:description><gtr:id>9AE73344-BEED-48B4-AAEE-FB704C1DF8FE</gtr:id><gtr:impact>PMID:19143628</gtr:impact><gtr:outcomeId>B3D7A51F36D-3</gtr:outcomeId><gtr:partnerContribution>Program provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagentsProgram provides complementary experimental systems and access to reagents</gtr:partnerContribution><gtr:piContribution>We provide cell biological expertise and experimental models</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Open day/Science Fair</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7CFDAF47-AEF6-4BD9-9F9B-126DCE5798A8</gtr:id><gtr:impact>An open day/science fair for MRC funded researchers at UCL - LMCB a principle host and organiser. 500 members of public attended and took part in lectures, demonstrations and other events. Part of MRC Centenary celebrations.

Significant feedback from public impressed by presentations and visibility of MRC funded research.</gtr:impact><gtr:outcomeId>JcSjMXDLg2B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/lmcb/lmcb-takes-lead-mrc-centenary-celebrations-ucl</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Naked Scientist/Radio Cambridgeshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C7F054B-CBD6-4348-A4FC-87D7CA589E1A</gtr:id><gtr:impact>Participation in weekly radio science program - the Naked Scientists - BBC Radio Cambridgeshire and Podcast. Radio show has audience of ~50,000.

Positive feedback from listeners</gtr:impact><gtr:outcomeId>bb5JsUS2Dwi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Public Panel presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2BB7AE47-B216-44CB-BC31-E4718C8D6BAC</gtr:id><gtr:impact>Members of MRC Public Panel came to CBU/LMCB for afternoon to hear talks from myself, other CBU group leaders and MRC Chief Operating Officer (John Jeans)

Positive feedback from panel members</gtr:impact><gtr:outcomeId>DnjTRH5GAuV</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dartford  Grammar School Science College, Inaugural Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9F7C1BDA-94EB-44C4-8574-7AC748FA52B2</gtr:id><gtr:impact>Inaugural lecture for new Science College

Increase awareness of MRC activities, Cell Biology Units work</gtr:impact><gtr:outcomeId>7C5D968826D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Showcase on Infection and Immunity</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94227790-1E72-4E24-B923-2B11BCE77F4F</gtr:id><gtr:impact>Poster presentation by group members (A. Pelchen-Matthews, M. Deneka) at MRC Showcase on Infection and Immunity

Improved awareness of team's work</gtr:impact><gtr:outcomeId>BA3564A3227</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>99951</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL MRC Confidence in Concepts</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC-PC-12024</gtr:fundingRef><gtr:id>439054E2-905B-415B-88A2-297C505F148F</gtr:id><gtr:outcomeId>nVQ5mBdzNqk</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EC FP7 funding</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C840C5F4-B4F1-4C4F-9F7E-B83591F7A3D9</gtr:id><gtr:outcomeId>4222AA927140</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4268BF63-A2B6-4C2D-8D7F-77E4B1C9A57C</gtr:id><gtr:outcomeId>4411DE3D8800</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Two monoclonal antibody reagents for primate lysosomal membrane proteins. These antibodies are used as morphological markers of the endocytic pathway in studies of HIV replication, dementia, growth factor receptor trafficking, etc.</gtr:description><gtr:id>B5737C4B-500C-4D2C-83B7-DE681D2437A1</gtr:id><gtr:impact>Useful in a variety of cell biological applications - further uses remain to be established.</gtr:impact><gtr:outcomeId>3C98712105B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>1B5, 2C2</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>742423EF-0011-4425-A726-F83BF7CCA38E</gtr:id><gtr:title>Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1E45F4793E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AD02E41-30ED-4B46-BEA3-270BFA3A9F4C</gtr:id><gtr:title>Single-cell analysis of population context advances RNAi screening at multiple levels.</gtr:title><gtr:parentPublicationTitle>Molecular systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fac174afe28bb87d904db22952030ec"><gtr:id>5fac174afe28bb87d904db22952030ec</gtr:id><gtr:otherNames>Snijder B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>54634578d1c7b2.61565001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAF1FAE1-D2CC-4552-8F75-643D573F0962</gtr:id><gtr:title>The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca3e8c6cdce25fd53c6b8442594b24f4"><gtr:id>ca3e8c6cdce25fd53c6b8442594b24f4</gtr:id><gtr:otherNames>Janvier K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>XU2tkhjTaA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C258C91-ED28-4FF1-9764-5FE02840A259</gtr:id><gtr:title>The role of ubiquitination in lysosomal trafficking of d-opioid receptors.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dedd8ab7f14018bb199900724ef8a37"><gtr:id>3dedd8ab7f14018bb199900724ef8a37</gtr:id><gtr:otherNames>Henry AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>Dr9V8trXqDM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF3EFDF9-9A35-4628-8EA2-C6FC680FD14E</gtr:id><gtr:title>The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b61f1348cf1bd388f331085ec5b0b78"><gtr:id>1b61f1348cf1bd388f331085ec5b0b78</gtr:id><gtr:otherNames>Bongers G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>cfis9p6ahXn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE106C3C-A5D1-422F-99D9-6A9EE01CAE29</gtr:id><gtr:title>The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c9160a0267820553c90b6b55dee68ca"><gtr:id>0c9160a0267820553c90b6b55dee68ca</gtr:id><gtr:otherNames>Nkwe DO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>585d3c5658f975.70068442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74BECC3A-192C-4A49-B28A-05ED0E817093</gtr:id><gtr:title>HIV assembly and budding in macrophages.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/767df1a9232354feb7b48f3aca089c0a"><gtr:id>767df1a9232354feb7b48f3aca089c0a</gtr:id><gtr:otherNames>Marsh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>EBCB6D12523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABF82AEC-FEED-4994-A709-211AEEEB0EA5</gtr:id><gtr:title>Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba2e2fac0f65c8930d600178b0e65427"><gtr:id>ba2e2fac0f65c8930d600178b0e65427</gtr:id><gtr:otherNames>Azevedo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5FE1E53275C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C35D7A6-2F5E-4305-B084-AE2C09AC2220</gtr:id><gtr:title>Organization and regulation of intracellular plasma membrane-connected HIV-1 assembly compartments in macrophages.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>doi_13098_7007_11_89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D6608B3-318E-4C1E-8C75-C6EB619EFEF0</gtr:id><gtr:title>Alphavirus Restriction by IFITM Proteins.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f9fb420a45ace05ff5b1c6fc5fbd0a"><gtr:id>25f9fb420a45ace05ff5b1c6fc5fbd0a</gtr:id><gtr:otherNames>Weston S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>585d3a3d740277.63322434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC06F34-562B-4A11-A53E-4E0B2C339C1C</gtr:id><gtr:title>Analysis of chemokine receptor endocytosis and intracellular trafficking.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/439c5e05c5ba8cc8228f18d7270a10b0"><gtr:id>439c5e05c5ba8cc8228f18d7270a10b0</gtr:id><gtr:otherNames>Kershaw T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>ED1402E7A62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>107BE95B-D50E-45F3-82F4-5537172E4FAA</gtr:id><gtr:title>Endosomes</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/767df1a9232354feb7b48f3aca089c0a"><gtr:id>767df1a9232354feb7b48f3aca089c0a</gtr:id><gtr:otherNames>Marsh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:isbn>0-387-39950-X</gtr:isbn><gtr:outcomeId>485E88EFCDD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2579A02D-504C-4C4B-92B2-9A57D75FC538</gtr:id><gtr:title>Diacylglycerol kinase a regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc4a52c2cb0d4e8ca4853b7b5379b6d4"><gtr:id>cc4a52c2cb0d4e8ca4853b7b5379b6d4</gtr:id><gtr:otherNames>Alonso R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>AiPMAfgaski</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40F8342C-9E3E-4503-87E5-B0A0AA3AAB6F</gtr:id><gtr:title>?2 integrin adhesion complexes maintain the integrity of HIV-1 assembly compartments in primary macrophages.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0d69886d2e66354786b299457a20807"><gtr:id>b0d69886d2e66354786b299457a20807</gtr:id><gtr:otherNames>Pelchen-Matthews A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>NxUU5DBwccJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A59EB68-577F-40F8-A1F4-65BFD9AEA9C5</gtr:id><gtr:title>3D correlative light and electron microscopy of cultured cells using serial blockface scanning electron microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f80858efd508ebfee9eabaa0ff0bc2f"><gtr:id>9f80858efd508ebfee9eabaa0ff0bc2f</gtr:id><gtr:otherNames>Russell MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>585d3dac615811.33345484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>958BD2F0-A63B-4BF2-AB73-E33D3DD3B5CF</gtr:id><gtr:title>The cell biology of receptor-mediated virus entry.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe40ce492da64d8686da83c7038b7e65"><gtr:id>fe40ce492da64d8686da83c7038b7e65</gtr:id><gtr:otherNames>Grove J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>ReRkCn6r7G6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B12ED890-ADA1-4122-A3CD-1A0847FDC495</gtr:id><gtr:title>Advances in HIV-1 Assembly and Release</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45fb2de80944cf29b6ea3427d38d6df7"><gtr:id>45fb2de80944cf29b6ea3427d38d6df7</gtr:id><gtr:otherNames>Giese S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-1-4614-7728-0</gtr:isbn><gtr:outcomeId>J6UgEAYJk6K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B488850-B1C4-4B0C-B0F3-151B674E9C51</gtr:id><gtr:title>Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8eb3ac95f6cf8606257c937ca52bece9"><gtr:id>8eb3ac95f6cf8606257c937ca52bece9</gtr:id><gtr:otherNames>Tippett E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>54634457d35d85.40897494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E3A2D00-7E79-4585-B462-1CAEC84B003D</gtr:id><gtr:title>HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48e56a92c0a0de1239ae8f016f8b2bf"><gtr:id>c48e56a92c0a0de1239ae8f016f8b2bf</gtr:id><gtr:otherNames>Slinger E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>YHEbX24CTFw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78255D6D-C18A-4597-8649-F1CA06A92B2B</gtr:id><gtr:title>Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e46d4f7f3d0fd5771d96152a22af04"><gtr:id>16e46d4f7f3d0fd5771d96152a22af04</gtr:id><gtr:otherNames>Blondeau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13098_28_24067975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A918A44-6FD0-4440-A412-CE212FFEA858</gtr:id><gtr:title>Regulation of endocytic clathrin dynamics by cargo ubiquitination.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dedd8ab7f14018bb199900724ef8a37"><gtr:id>3dedd8ab7f14018bb199900724ef8a37</gtr:id><gtr:otherNames>Henry AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_13098_28_22940114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9204EE-EABA-4485-92DC-BF3EA394BEE4</gtr:id><gtr:title>Rab7A is required for efficient production of infectious HIV-1.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3d03e2f13f88c91aca68156f7893562"><gtr:id>a3d03e2f13f88c91aca68156f7893562</gtr:id><gtr:otherNames>Caillet M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>RxipW1nj8AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8A21B5-1F56-41D2-A82B-0A33650513BA</gtr:id><gtr:title>Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f36a0f1f27651c2f7085c8fa36a16c8"><gtr:id>0f36a0f1f27651c2f7085c8fa36a16c8</gtr:id><gtr:otherNames>Smith AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>snmFxu7xzL6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U122665002</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>